# A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

> **NCT05720702** · EARLY_PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 31 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** homocysteine (Hcy) lowering supplements

## Key facts

- **NCT ID:** NCT05720702
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-30
- **Primary completion:** 2024-08-23
- **Final completion:** 2024-08-23
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720702, "A Feasibility Trial of OCM Supplements for the Treatment of NAFLD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05720702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*